
Henning Willers MD
Associate Professor of Radiation Oncology, Harvard Medical School; Director, Thoracic Radiation Oncology Program; Massachusetts General Hospital
Join to View Full Profile
MASSACHUSETTS GENERAL HOSPITAL55 Fruit StreetBoston, MA 02114
Phone+1 617-726-5184
Dr. Willers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2001 - 2005
- St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 2000 - 2001
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Radiation Oncology, 1996 - 1999
- St. George HospitalResidency, Radiation Oncology , 1994 - 1996
- University Hamburg, Krankenhaus Eppendorf, Fak MedClass of 1994, MD, Magna cum laude
Certifications & Licensure
- MA State Medical License 2004 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Differentiation stage predicts radiosensitivity in mesenchymal-like pancreatic cancer.Tingshi Su, Xinjian Yu, Mojtaba Hoseini-Ghahfarokhi, David B Flint, Scott J Bright
International Journal of Radiation Oncology, Biology, Physics. 2025-04-01 - Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kina...Florence K Keane, Beow Y Yeap, Melin J Khandekar, Jessica J Lin, Ibiayi Dagogo-Jack
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15 - Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models.Shan Lu, Xiao Pan, Eva Volckova, Anjali Shinde, Schuyler R Fuller
Molecular Cancer Therapeutics. 2025-01-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: